Healius (ASX:HLS) Net Interest Margin (Bank Only) %


ASX:HLS Healius Ltd ASX:HLS
53 GF Score
Price A$0.37
GF Value A$1.01
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Healius Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ASX:HLS
53GF Score
Healius Ltd ASX:HLS
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Healius (ASX:HLS) Overvalued in 2026?

Based on GuruFocus' analysis, Healius stock appears to be undervalued. The current stock price of A$0.37 is trading 63.9% below its estimated GF Value™ of A$1.01. GuruFocus considers Healius to be Possible Value Trap.

Key valuation signals for ASX:HLS:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: A$1.01 vs. price of A$0.37 (63.9% below fair value)
  • GF Score™: 53/100 with 7 warning signs

No single metric tells the full story. See the ASX:HLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healius Business Description

Other Exchanges PGZ:Germany
Address 161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
53GF Score

Get the complete analysis for ASX:HLS

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.37
Price
A$1.01
GF Value